摘要
探析临床药师主导的药学强化干预对高血压患者出现缺血性脑卒中风险的影响。选取2020年1月—2021年12月在临沂市第三人民医院进行治疗的150例高血压患者为研究对象,随机将其分为常规组和研究组,每组各75例。常规组行常规干预,研究组行临床药师主导的药学强化干预,比较干预前后两组患者的缺血性脑卒中的发生概率。结果显示,干预后,研究组患者血压控制情况优于常规组;服药依从性高于常规组;血压、血脂和血糖等指标的达标率高于常规组;缺血性脑卒中的发生概率低于常规组。以上观察指标比较,差异均有统计学意义(P<0.05)。研究发现,对高血压患者实施以临床药师为主导的药学强化干预,能有效降低患者发生缺血性脑卒中的风险。
Exploring the impact of pharmaceutical intensive intervention led by clinical pharmacists on the risk of ischemic stroke in hypertensive patients.150 hypertensive patients treated at Linyi Third People’s Hospital from January 2020 to December 2021 were selected as the research subjects and randomly divided into a control group and a study group,with 75 patients in each group.The routine group received routine intervention,while the study group received pharmaceutical intensive intervention led by clinical pharmacists.The probability of ischemic stroke occurrence before and after intervention was compared between the two groups of patients.The results showed that after intervention,the blood pressure control in the study group was better than that in the control group;The medication adherence was higher than that of the control group;The compliance rate of indicators such as blood pressure,blood lipids,and blood glucose was higher than that of the control group;The incidence of ischemic stroke is lower in the control group than in the control group.The above observed indicators showed statistically significant differences(P<0.05).Research has found that implementing pharmaceutical intensive interventions led by clinical pharmacists for hypertensive patients can effectively reduce the risk of ischemic stroke.
作者
王红岩
高媛
Wang Hongyan(Linyi Third People’s Hospital,Linyi,Shandong 276000)
出处
《科技与健康》
2024年第15期53-56,共4页
Technology and Health
关键词
临床药师主导
药学强化干预
高血压
血性脑卒中风险
应用效果
clinical pharmacist led
pharmaceutical reinforcement intervention
hypertension
risk of hemorrhagic stroke
application effect
